Journals / Güncel Retina Dergisi / 2021 / Cilt: 5 - Sayı: 1

Serpiginous Choroiditis; Clinical Features, Diagnosis and Treatment

Serpijinöz Koroidit; Klinik Özellikler, Tanı ve Tedavi

Pages
10–17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

If an underlying infectious agent is detected, specific antimicrobial treatment should also be added.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Serpiginous choroiditis is a progressive disease that causes atrophy in layers of choriocapillaris, retinal pigment epithelium and photoreceptor, due to choroidal inflammation.
📊
Key Findings & Data:It typically involves both eyes asymmetrically and spreads from the peripapillary area to the periphery.
💡
Conclusion & Impact:If an underlying infectious agent is detected, specific antimicrobial treatment should also be added.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Serpiginous choroiditis is a progressive disease that causes atrophy in layers of choriocapillaris, retinal pigment epithelium and photoreceptor, due to choroidal inflammation. It typically involves both eyes asymmetrically and spreads from the peripapillary area to the periphery. Although the etiology is unclear, autoimmune and infectious mechanisms seems likely to be underlying process. The clinical condition is called “multifocal serpiginoid choroiditis” if an underlying infectious cause such as Mycobacterium tuberculosis, Treponema pallidum or herpesviruses is detected. The natural course of the disease, usually consists of multipl recurrences of choroidal inflammation over a period of months to years. The vision loss occurs if the fovea is involved during these relapses. Multimodal imaging methods are important in the diagnosis, treatment, follow-up of the disease and the detection of complications such as choroidal neovascularization. In treatment, it is aimed to supress inflammation and prevent recurrences via systemic/local corticosteroids and immunomodulatory drugs. If an underlying infectious agent is detected, specific antimicrobial treatment should also be added.

Özet

Serpijinöz koroidit, koroid inflamasyonu nedeniyle koryokapillaris, retina pigment epiteli ve fotoreseptör tabakada atrofiye neden olan progresif bir hastalıktır. Genellikle asimetrik bilateral tutulum yapar ve peripapiller alandan perifere doğru yayılır. Etyolojisi bilinmemekle birlikte ön planda otoimmun ve enfeksiyöz mekanizmalar suçlanmaktadır. Eğer Mycobacterium tuberculosis, Treponema pallidum ya da herpesvirusler gibi altta yatan enfeksiyöz bir neden bulunursa, klinik durum “multifokal serpijinoid koroidit” olarak adlandırılır. Hastalığın doğal seyrinde aylar ya da yıllar içinde koroidal inflamasyon defalarca nüks eder. Bu nüksler sırasında fovea tutulursa görme kaybı gelişir. Hastalığın tanı, tedavi, takibinde ve koroidal neovaskülarizasyon gibi komplikasyonların tanınmasında multimodal görüntüleme yöntemleri önemlidir. Tedavide amaç sistemik/lokal kortikosteroidler ve immunmodulatör ilaçlar ile inflamasyonun baskılanması ve nükslerin önlenmesidir. Altta yatan enfeksiyöz bir neden varsa etkene yönelik antimikrobiyal tedavi yapılmalıdır.

🔖

Cite This Article

GÜNDÜZ, G. U., GELİŞKEN, Ö., YALÇINBAYIR, Ö. (2021). Serpiginous Choroiditis; Clinical Features, Diagnosis and Treatment. Güncel Retina Dergisi, Cilt: 5 - Sayı: 1, 10–17. https://ajindex.com/articles/219682

References (16)

  1. Dutta Majumder P, Biswas J, Gupta A. Enigma of serpiginous choroiditis. Indian J Ophthalmol. 2019;67(3):325-33
  2. Nazari Khanamiri H, Rao NA. Serpiginous choroiditis and infectious multifocal serpiginoid choroiditis. Surv Ophthalmol. 2013;58(3):203-32
  3. Hutchinson J. Serpiginous choroiditis in scrofulous subjects: choroidal lupus. Arch Surg (Lond). 1900;11:126–35
  4. Biswas J, Narain S, Das D, Ganesh SK. Pattern of uveitis in a referral uveitis clinic in India. Int Ophthalmol. 1996;20(4):223–8
  5. Broekhuyse RM, van Herck M, Pinckers AJ, Winkens HJ, van Vugt AH, Ryckaert S, et al. Immune responsiveness to retinal S-antigen and opsin in serpiginous choroiditis and other retinal diseases. Doc Ophthalmol. 1988;69(1):83–93
  6. Erkkilä H, Laatikainen L, Jokinen E. Immunological studies on serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 1982;219:131–4
  7. Lim WK, Buggage RR, Nussenblatt RB. Serpiginous choroiditis. Surv Ophthalmol. 2005;50(3):231-44
  8. Rao NA, Saraswathy S, Smith RE. Tuberculous uveitis: Distribution of mycobacterium tuberculosis in the retinal pigment epithelium. Arch Ophthalmol. 2006;124:1777–9
  9. Gass JDM. Stereoscopic Atlas of Macular Diseases: A Funduscopic and Angiographic Presentation. St Louis: CV Mosby Co; 1997;158–65
  10. Priya K, Madhavan HN, Reiser BJ, Biswas J, Saptagirish R, Narayana KM, et al. Association of herpesviruses in the aqueous humor of patients with serpiginous choroiditis: a polymerase chain reaction-based study. Ocul Immunol Inflamm. 2002;10(4):247–61
  11. Laatikainen L, Erkkilä H. A follow-up study on serpiginous choroiditis. Acta Ophthalmol (Copenh). 1981;59(5):707–18
  12. Mansour AM, Jampol LM, Packo KH, Hrisomalos NF. Macular serpiginous choroiditis. Retina. 1988;8(2):125–31
  13. Gupta V, Agarwal A, Gupta A, Bambery P, Narang S. Clinical characteristics of serpiginous choroidopathy in North India. Am J Ophthalmol. 2002;134(1):47–56
  14. Weiss H, Annesley WH, Shields JA, Tomer T, Christopherson K. The clinical course of serpiginous choroidopathy. Am J Ophthalmol. 1979;87:133– 42 15. Sahu DK, Rawoof A, Sujatha B. Macular serpiginous choroiditis. Indian J Ophthalmol. 2002;50(3):189–96
  15. Cardillo Piccolino F, Grosso A, Savini E. Fundus autofluorescence in serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol. 2009;247(2):179– 85
  16. Agarwal A, Agrawal R, Khandelwal N, Invernizzi A, Aggarwal K, Sharma A, et al. Choroidal structural changes in tubercular multifocal serpiginoid choroidit